Literature DB >> 12917205

Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.

Nicole M Probst-Hensch1, Hao Wang, Victor H H Goh, Adeline Seow, Hin-Peng Lee, Mimi C Yu.   

Abstract

Variation in the circulating concentrations of the insulin-like growth factor (IGF) system has been implicated in the etiology of chronic diseases including cancer (prostate, breast, colon, and lung), heart disease, type 2 diabetes, and osteoporosis. We searched for sociodemographic, anthropometric, reproductive, lifestyle, and dietary determinants of IGF-I and insulin-like growth factor binding protein (IGFBP) -3 serum concentrations. Serum samples were collected in a Singapore Chinese cohort with a mean age of 61 years. Subject information was assessed during an in-person interview. Radioimmunometrically measured IGF-I and IGFBP-3 concentrations were available for 312 men and 326 postmenopausal women ages 50 years or older. Mean IGF-I concentrations were 144 ng/ml and 121 ng/ml for men and women, respectively (gender difference, P < 0.0001), and mean IGFBP-3 concentrations were 3710 ng/ml and 4147 ng/ml for men and women, respectively (gender difference, P < 0.0001). IGF-I and IGFBP-3 decreased with age (P for trend <0.0001); the age-related decrease in the IGF-I:IGFBP-3 molar ratio was stronger in women than men. IGF-I concentrations were higher among physically inactive subjects and among women with an early age at menarche. Consumption of saturated fat was found to decrease, and intake of omega-3 polyunsaturated fatty acids and of dietary fiber was found to increase circulating IGFBP-3 concentrations. Intake of calcium from food and supplement was associated positively with circulating IGF-I, IGFBP-3, and molar ratio. Intake of soy was associated positively with IGF-I and molar ratio concentrations, but only in men. The results of this study lend additional support to the hypothesis that circulating IGF-I concentrations increase the risk of prostate, bladder, colorectal, and breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917205

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

1.  Body composition in children with galactosaemia.

Authors:  B Panis; P Ph Forget; F H Nieman; M J P G van Kroonenburgh; M E Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  IGFBP3 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Li Li; Xin Huang; Keke Huo
Journal:  Mol Biol Rep       Date:  2009-05-18       Impact factor: 2.316

3.  Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women.

Authors:  Jane Teas; Mohammad R Irhimeh; Susan Druker; Thomas G Hurley; James R Hébert; Todd M Savarese; Mindy S Kurzer
Journal:  Nutr Cancer       Date:  2011-06-28       Impact factor: 2.900

4.  Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development.

Authors:  Reza Hakkak; Saied Shaaf; Chan Hee Jo; Stewart Macleod; Soheila Korourian
Journal:  Oncol Lett       Date:  2010-11-08       Impact factor: 2.967

Review 5.  Does soy protein affect circulating levels of unbound IGF-1?

Authors:  Mark Messina; Pamela Magee
Journal:  Eur J Nutr       Date:  2017-04-22       Impact factor: 5.614

6.  Associations of serum insulin-like growth factor-I and insulin-like growth factor-binding protein 3 levels with biomarker-calibrated protein, dairy product and milk intake in the Women's Health Initiative.

Authors:  Jeannette M Beasley; Marc J Gunter; Andrea Z LaCroix; Ross L Prentice; Marian L Neuhouser; Lesley F Tinker; Mara Z Vitolins; Howard D Strickler
Journal:  Br J Nutr       Date:  2013-10-07       Impact factor: 3.718

7.  Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults.

Authors:  David Berrigan; Nancy Potischman; Kevin W Dodd; Stephen D Hursting; Jackie Lavigne; J Carl Barrett; Rachel Ballard-Barbash
Journal:  Growth Horm IGF Res       Date:  2008-09-21       Impact factor: 2.372

8.  Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.

Authors:  Jay H Fowke; Charles E Matthews; Herbert Yu; Qiuyin Cai; Sarah Cohen; Maciej S Buchowski; Wei Zheng; William J Blot
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

9.  Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors:  Konstantinos K Tsilidis; Ruth C Travis; Paul N Appleby; Naomi E Allen; Sara Lindström; Demetrius Albanes; Regina G Ziegler; Marjorie L McCullough; Afshan Siddiq; Aurelio Barricarte; Sonja I Berndt; H Bas Bueno-de-Mesquita; Stephen J Chanock; E David Crawford; W Ryan Diver; Susan M Gapstur; Edward Giovannucci; Fangyi Gu; Christopher A Haiman; Richard B Hayes; David J Hunter; Mattias Johansson; Rudolf Kaaks; Laurence N Kolonel; Peter Kraft; Loic Le Marchand; Kim Overvad; Silvia Polidoro; Elio Riboli; Fredrick R Schumacher; Victoria L Stevens; Dimitrios Trichopoulos; Jarmo Virtamo; Walter C Willett; Timothy J Key
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

10.  Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.

Authors:  Cathrine Hoyo; Janet Grubber; Wendy Demark-Wahnefried; Bruce Lobaugh; Amy S Jeffreys; Steven C Grambow; Jeffrey R Marks; Temitope O Keku; Phillip J Walther; Joellen M Schildkraut
Journal:  J Natl Med Assoc       Date:  2009-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.